【摘要】 目的 探讨社区标准化代谢病管理平台(MMC)在早期老年糖尿病肾病患者管理中的应用效果。方法 选择2022年1月至2023年12月在本中心就诊的132例早期老年糖尿病肾病患者，采用随机数字表法分为对照组和研究组，每组66例。对照组接受常规管理，研究组在对照组基础上采用MMC进行管理。比较两组患者干预前后血糖控制情况、肾功能指标及并发症发生率。结果 干预6个月后，研究组患者空腹血糖(FPG)、餐后2小时血糖(2hPG)、糖化血红蛋白(HbA1c)水平均显著低于对照组(P<0.05)。研究组患者肾小球滤过率(eGFR)显著高于对照组，尿微量白蛋白/肌酐比值(UACR)显著低于对照组(P<0.05)。研究组患者并发症发生率显著低于对照组(P<0.05)。结论 MMC可有效改善早期老年糖尿病肾病患者的血糖控制效果和肾功能，降低其并发症发生率。更多还原

【Abstract】 Objective:To explore the application effect of Community Standardized Metabolic Disease Management Platform(MMC) in the management of early elderly diabetic nephropathy patients.Methods:132 cases of early senile diabetic nephropathy in our center from January 2022 to December 2023 were randomly divided into control group and research group, with 66 cases in each group.The control group received routine management, while the study group utilized MMC.Blood glucose control, renal function indicators, and complication rates were assessed before and after a 6-month intervention.Results:Post-intervention, the study group showed significantly lower levels of FPG、2hPG and HbA1c compared to the control group(P<0.05).The study group also demonstrated higher eGFR and lower UACR(P<0.05).Moreover, the complication rate was significantly reduced in the study group(P<0.05).Conclusion:The Community Standardized Metabolic Disease Management Platform(MMC) can effectively improve blood glucose control and renal function, and reduce the incidence of complications in early elderly diabetic nephropathy patients, which is worthy of clinical promotion and application.更多还原